Search

You searched for "ophthalmologists"

3289 results found

Introducing: iGLEAMS-3

2 February 2024 | conferences, iGLEAMS, MiGS, Glaucoma, Surgery, Simulation, Education, Events, AHP
30 September (Colchester FirstSite) – 1 October (Colchester ICENI Centre)

Passing the Refraction Certificate as a Foundation doctor

3 April 2023 | | EYE - Cataract, EYE - Refractive, EYE - General
Application for ophthalmic specialist training (OST) is competitive. This means you should consider making every effort to maximise your portfolio points, as it may have a significant contribution to your OST application ranking. The “Commitment to Specialty” section is the...

Developments in retinal pigmentation measurement and the hopes of an equitable future

4 August 2025 | | EYE - Vitreo-Retinal, EYE - Imaging
Our AI & Oculomics co-editor, Nima Ghadiri, sat down with Abraham Olvera-Barrios from Moorfields and Anand Rajesh from the University of Washington to discuss their recent international study into retinal pigmentation and its wider clinical, technological and academic applications. Can...

South-South collaboration for the treatment of avoidable blindness in Botswana

1 October 2017 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
This article describes the value of South-South collaboration in the reduction of avoidable blindness. Specifically it describes a South-South collaboration between India and Botswana that evolved out of the VISION 2020 LINK between Cambridge University Hospitals, two institutions in India...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

Coming to terms with AI

1 August 2019 | | EYE - Imaging, EYE - Vitreo-Retinal, EYE - Glaucoma, EYE - General
A machine might be called intelligent if its response to questions could convince a person that it was human, a test proposed by Alan Turing in 1950 [1]. The author considers potential applications of artificial intelligence (AI) using machine learning...

A life outside ophthalmology

3 April 2023 | | EYE - General
Lloyd Paul Aiello. It was an absolute privilege to speak to Lloyd Paul Aiello, Professor of Ophthalmology, Harvard Medical School, and Vice President of Ophthalmology and Director, Beetham Eye Institute, Joslin Diabetes Center, USA. Prof Aiello is a third-generation ophthalmologist,...

Inter-deanery transfers

3 February 2026 | | EYE - General
In the past, a system existed for when unexpected circumstances arose, with trainees from one part of the country being able to apply to relocate to another part without losing out on training time. This was mainly because of marriage,...

Report on preoperative visual acuities of patients from two AMM surgical trips to Magdalena, Northern Bolivia

3 October 2024 | | EYE - Glaucoma, EYE - General
The Andean Medical Mission (AMM), founded in 2012, recently celebrated 12 years of dedicated service in the Bolivian Amazon, aiming to eliminate avoidable blindness. Over this period, AMM has successfully performed over 1700 surgeries, including for children with congenital or...

How to access research funding- experiences from the inside track @ 100% Ophthalmology

24 February 2024
@15:15 – 16:15 The panel will aim to encourage members of the audience to consider applying to Fight for Sight and other vision charities.

Allied eye healthcare networking @ 100% Ophthalmology

24 February 2024
@16:15 – 17:00 With technology advancing so much, SD-OCT is a more sensitive diagnostic tool than wide field FAF imaging for detecting early-stage HCQ-induced maculopathy. Wide field FAF may not be a necessary addition to SD-OCT in detecting HCQ toxicity. Richard Bell, Co-Chair - British Association of Retinal Screening

Implementing technology to improve global eye health

3 October 2024 | | EYE - Vitreo-Retinal
Technological innovation is providing new solutions to transform global eye health [1–5]. In particular, research towards the development of artificial intelligence (AI) tools in ophthalmology has gained pace in recent years. However, there has been little research relating to its...